NICE rejects omalizumab for asthma in children | GP online
Links shared publicly online about this topic.
- 954total visits
NICE rejects omalizumab for asthma in children | GP online
Using omalizumab (Xolair) to treat children with persistent allergic asthma does not represent good value for NHS money, NICE has said.
View full resource at gponline.com
Tags: Allergies, Asthma, Asthma Medication, Children's Asthma, Allergic Asthma, Children's Health, Xolair
Most Recently Shared on August 12, 2010 at 9:26 am By:
NICE rejects omalizumab for asthma in children http://bit.ly/9EiIVy
NICE rejects asthma drug for under-12s | GP online
gponline.com — “NICE has rejected asthma drug omalizumab (Xolair) for children under the age of 12 in the NHS in England and issued guidance on fracture prevention, bed-wetting treatments and the diabetes drug liraglutide.” View full resource at gponline.com
Most Recently Shared on October 27, 2010 at 10:12 am By:
GPonline.com Medical Education and Medical Publisher
NICE rejects asthma drug for under-12s http://bit.ly/9NtNhB
Advertisement
